Research on this question remains limited, but available evidence suggests that effects on reward circuitry may diminish after discontinuing GLP-1 medications
Distribution Sites Only Pick up your FREE sharps container at any of the following distribution sites
Asprey, 46, founder of food and supplement company Bulletproof 360 and a former Silicon Valley technology executive, does not have a science or clinical background, but he says he has spent more than $1 million and two decades "biohacking" himself with supplements, devices and neurology equipment
These medications, commonly administered via injections, are referred to as GLP-1 receptor agonists
Report of one case]
These medications may create changes in your gut microbiome that can be challenging as your body adapts to treatment but can also be manageable with the right knowledge and support